Rescind the NIH decision to drastically reduce grant funding for indirect costs and work with Congress to protect biomedical research funding.

Nydia M. Velázquez · New York · Democratic

policy impact 3.00 specificity 1.00 extraction confidence 98%

Contest this claim

Occurrences

We strongly urge you to rescind this decision and work with Members of Congress to ensure that any proposed changes lead to more jobs for the American people and more cutting-edge research that allows the United States to remain at the forefront of scientific progress and advancement.

Velázquez joined a letter calling on NIH to reverse the 15 percent cap on indirect research costs and work with lawmakers on changes that preserve jobs and research progress.

REPS. VELÁZQUEZ, MORELLE, GOLDMAN, TONKO, CALL OUT NATIONAL INSTITUTES OF HEALTH FOR DEVASTATING CUTS TO GRANT FUNDING | Congresswoman Nydia Velázquez
primary · press_release · model gpt-5.4-mini

Evidence

Velázquez joined a bipartisan, bicameral New York delegation letter criticizing NIH's 15% indirect-cost cap and urging the agency to rescind the decision and work with Congress to protect research jobs and biomedical research.

Direct congressional action on the same issue: the press release documents Velázquez helping lead a formal letter to NIH asking for reversal of the indirect-cost cut and coordination with Congress.

partial same_term A for effort

REPS. VELÁZQUEZ, MORELLE, GOLDMAN, TONKO, CALL OUT NATIONAL INSTITUTES OF HEALTH FOR DEVASTATING CUTS TO GRANT FUNDING | Congresswoman Nydia Velázquez
primary · model gpt-5.4-mini · confidence 98%

Contest this evidence item

NIH's notice sets a standard 15% indirect rate across NIH grants and applies it to new and existing awards, indicating the policy was not rescinded in the notice itself.

Official NIH guidance documents the challenged policy and shows the 15% cap was adopted; no later reversal is reflected on this notice page.

never same_term

NOT-OD-25-068: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates
secondary · model gpt-5.4-mini · confidence 97%

Contest this evidence item

Assessments

never same_term A for effort

Velazquez materially advanced the issue by joining a formal bipartisan, bicameral letter urging NIH to rescind the 15% indirect-cost cap and work with Congress, but the cited NIH guidance shows the cap remained in place and no rescission is evidenced. That makes this a serious attempt that did not achieve the promised outcome.

provider codex_cli · model gpt-5.4-mini · confidence 97%